| Aktsiad | 268,294 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Healthcare - KRW | 15.7.2011 | 35 760,87 | 4,23 | 55,71 |
| Aktsiad | 170,836 mld. | - | Tiger ETF | 0,45 | Tervishoid | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 9686,69 | 8,62 | 29,81 |
| Aktsiad | 137,434 mld. | - | KODEX | 0,45 | Tervishoid | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 7757,18 | 3,79 | 27,02 |
| Aktsiad | 126,626 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 7155,17 | 5,96 | 117,75 |
| Aktsiad | 108,077 mld. | - | KODEX | 0 | Tervishoid | | 3.8.2023 | 12 666,93 | 5,51 | 49,41 |
| Aktsiad | 84,316 mld. | - | KODEX | 0,45 | Tervishoid | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 833,88 | 10,27 | 36,62 |
| Aktsiad | 77,807 mld. | - | KODEX | 0,09 | Tervishoid | KRX Healthcare - KRW | 28.3.2017 | 16 147,44 | 4,22 | 55,70 |
| Aktsiad | 55,713 mld. | - | Tiger ETF | 0,30 | Tervishoid | NASDAQ Biotechnology Index | 26.8.2014 | 22 698,81 | 4,29 | 21,25 |
| Aktsiad | 38,539 mld. | 6,269 mln. | SPDR | 0,09 | Tervishoid | Health Care Select Sector | 16.12.1998 | 144,07 | 5,20 | 28,71 |
| Aktsiad | 38,423 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 18 804,16 | 3,45 | 45,02 |
| Aktsiad | 37,104 mld. | - | Tiger ETF | 0 | Tervishoid | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 22 514,07 | 0 | 0 |
| Aktsiad | 32,814 mld. | - | Tiger ETF | 0,49 | Tervishoid | Solactive China Biotech Index - KRW - Benchmark TR Net | 3.12.2020 | 5797,04 | 2,95 | 25,33 |
| Aktsiad | 26,142 mld. | - | Hwabao | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,35 | 0 | 0 |
| Aktsiad | 24,193 mld. | - | E Fund | 0 | Tervishoid | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,39 | 0 | 0 |
| Aktsiad | 23,897 mld. | - | KODEX | 0,25 | Tervishoid | S&P Health Care Select Sector Index | 21.3.2023 | 12 143,90 | 5,17 | 28,53 |
| Aktsiad | 23,584 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 12 667,60 | 7,30 | 70,75 |
| Aktsiad | 18,023 mld. | - | KODEX | 0,25 | Tervishoid | S&P Biotechnology Select Industry | 31.10.2013 | 28 405,03 | 0 | 0 |
| Aktsiad | 17,195 mld. | 141 051,1 | Vanguard | 0,10 | Tervishoid | MSCI US IMI 25/50 Health Care | 26.1.2004 | 265,37 | 5,14 | 29,92 |
| Aktsiad | 13,34 mld. | - | Bosera | 0,65 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,39 | 0 | 0 |
| Aktsiad | 10,328 mld. | - | Kiwoom | 0,49 | Tervishoid | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 9484,64 | 4,93 | 25,02 |
| Aktsiad | 9,855 mld. | - | Samsung | 0,50 | Tervishoid | | 3.9.2024 | 9980,87 | 5,30 | 0 |
| Aktsiad | 6,816 mld. | - | Kiwoom | 0,49 | Tervishoid | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 9024,28 | 0 | 0 |
| Aktsiad | 6,747 mld. | 6,719 mln. | SPDR | 0,35 | Tervishoid | S&P Biotechnology Select Industry | 31.1.2006 | 94,28 | 4,99 | 0 |
| Aktsiad | 6,711 mld. | 1,055 mln. | iShares | 0,45 | Tervishoid | NYSE Biotechnology (TR) | 5.2.2001 | 136,10 | 4,98 | 24,34 |
| Aktsiad | 4,926 mld. | - | Tiger ETF | 0,50 | Tervishoid | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 13 766,09 | 2,44 | 23,03 |
| Aktsiad | 4,915 mld. | - | Tiger ETF | 0,40 | Tervishoid | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
| Aktsiad | 4,891 mld. | 480 330,4 | iShares | 0,40 | Tervishoid | DJ US Select / Medical Equipment | 1.5.2006 | 60,44 | 4,81 | 38,15 |
| Aktsiad | 4,361 mld. | - | Guotai | 0,60 | Tervishoid | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 0,96 | 0 | 0 |
| Aktsiad | 4,252 mld. | - | ChinaAMC | 0,65 | Tervishoid | Hang Seng Hong Kong-Listed Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,49 | 0 | 0 |
| Aktsiad | 4,203 mld. | - | NH-Amundi | 0,45 | Tervishoid | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 8305,63 | 2,24 | 17,30 |
| Aktsiad | 3,88 mld. | 114 652,6 | iShares | 0,41 | Tervishoid | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 90,21 | 4,61 | 26,80 |
| Aktsiad | 3,196 mld. | 221 262,6 | iShares | 0,39 | Tervishoid | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 60,68 | 5,19 | 29,01 |
| Aktsiad | 2,751 mld. | 129 271,6 | Fidelity | 0,08 | Tervishoid | MSCI US IMI 25/50 Health Care | 21.10.2013 | 68,42 | 4,99 | 28,33 |
| Aktsiad | 2,468 mld. | - | iShares | 0,15 | Tervishoid | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 11,34 | 5,17 | 28,53 |
| Aktsiad | 2,351 mld. | - | Xtrackers | 0,25 | Tervishoid | MSCI World Index / Health Care -SEC | 22.11.2010 | 52,90 | 4,64 | 27,05 |
| Aktsiad | 2,327 mld. | - | Guotai | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,43 | 0 | 0 |
| Aktsiad | 2,271 mld. | - | E Fund | 0,20 | Tervishoid | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 0,69 | 0 | 0 |
| Aktsiad | 2,146 mld. | - | NEXT FUNDS | 0,32 | Tervishoid | | 21.3.2008 | 27 623,78 | 1,75 | 26,27 |
| Aktsiad | 1,735 mld. | - | Ping An | 0,60 | Tervishoid | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 0 | 0 |
| Aktsiad | 1,722 mld. | - | Maxwealth | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,54 | 0 | 0 |
| Aktsiad | 1,602 mld. | - | Amundi | 0,50 | Tervishoid | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 10 827,50 | 3,96 | 21,30 |
| Aktsiad | 1,387 mld. | - | E Fund | 0,20 | Tervishoid | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,47 | 0 | 0 |
| Aktsiad | 1,381 mld. | - | iShares | 0,46 | Tervishoid | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 137,60 | 0 | 0 |
| Aktsiad | 1,352 mld. | - | Harvest ETFs | 1,06 | Tervishoid | | 19.11.2014 | 8,09 | 6,04 | 30,26 |
| Aktsiad | 1,157 mld. | 26 562,73 | First Trust | 0,62 | Tervishoid | StrataQuant Health Care Index | 8.5.2007 | 108,93 | 3,11 | 16,24 |
| Aktsiad | 1,132 mld. | 31 442,58 | First Trust | 0,56 | Tervishoid | NYSE Arca Biotechnology Index | 19.6.2006 | 166,83 | 4,70 | 31,02 |
| Aktsiad | 1,046 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 7,66 | 4,05 | 28,75 |
| Aktsiad | 1,046 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 7,66 | 4,05 | 28,75 |
| Aktsiad | 879,319 mln. | 73 014,91 | Invesco | 0,40 | Tervishoid | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 30,60 | 3,63 | 24,88 |
| Aktsiad | 870,957 mln. | 870 230,4 | Direxion | 0,96 | Tervishoid | S&P Biotechnology Select Industry | 28.5.2015 | 106,91 | 0 | 0 |
| Aktsiad | 787,738 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 145,14 | 3,11 | 22,13 |
| Aktsiad | 787,738 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 145,14 | 3,11 | 22,13 |
| Aktsiad | 782,08 mln. | - | E Fund | 0,20 | Tervishoid | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,41 | 0 | 0 |
| Aktsiad | 772,69 mln. | - | Fullgoal | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,91 | 0 | 0 |
| Aktsiad | 754,213 mln. | - | Amundi | 0,30 | Tervishoid | MSCI World Index / Health Care -SEC | 19.8.2010 | 488,53 | 4,05 | 23,77 |
| Aktsiad | 709,918 mln. | 66 641,07 | iShares | 0,40 | Tervishoid | DJ US Select / Health Care Providers | 1.5.2006 | 53,40 | 2,80 | 18,56 |
| Aktsiad | 657,056 mln. | - | iShares | 0,46 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 111,78 | 3,96 | 22,20 |
| Aktsiad | 656,977 mln. | - | SPDR | 0,18 | Tervishoid | MSCI Europe Health Care Index - EUR | 5.12.2014 | 214,28 | 3,99 | 21,51 |
| Aktsiad | 626,421 mln. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 58,12 | 5,20 | 28,99 |
| Aktsiad | 607,853 mln. | - | iShares | 0,25 | Tervishoid | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,19 | 4,16 | 22,04 |
| Aktsiad | 607,853 mln. | - | iShares | 0,25 | Tervishoid | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,19 | 4,16 | 22,04 |
| Aktsiad | 606,635 mln. | 156 369,8 | VanEck | 0,36 | Tervishoid | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 87,99 | 4,11 | 23,75 |
| Aktsiad | 600,953 mln. | - | iShares | 0,18 | Tervishoid | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 6,75 | 3,99 | 21,50 |
| Aktsiad | 596,243 mln. | 31 129,89 | iShares | 0,39 | Tervishoid | DJ US Select / Pharmaceutical | 1.5.2006 | 68,06 | 3,50 | 23,25 |
| Aktsiad | 589,994 mln. | - | SPDR | 0,30 | Tervishoid | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 61,10 | 5,08 | 25,68 |
| Aktsiad | 565,506 mln. | - | iShares | 0,66 | Tervishoid | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 70,12 | 0 | 0 |
| Aktsiad | 479,029 mln. | - | Fullgoal | 0,60 | Tervishoid | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 0,83 | 0 | 0 |
| Aktsiad | 468,556 mln. | - | iShares | 0,35 | Tervishoid | NASDAQ Biotechnology Index | 19.10.2017 | 6,48 | 0 | 0 |
| Aktsiad | 465,986 mln. | - | Invesco | 0,14 | Tervishoid | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 697,56 | 5,53 | 30,57 |
| Aktsiad | 455,097 mln. | - | Global X | 0,59 | Tervishoid | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1718,84 | 2,14 | 25,46 |
| Aktsiad | 436,018 mln. | - | ChinaAMC | 0,71 | Tervishoid | Hang Seng Hong Kong-Listed Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 8,74 | 2,37 | 15,81 |
| Aktsiad | 404,592 mln. | 3794,556 | VanEck | 0,35 | Tervishoid | MVIS US Listed Biotech 25 | 20.12.2011 | 162,36 | 4,97 | 30,13 |
| Aktsiad | 394,561 mln. | - | SPDR | 0,15 | Tervishoid | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 43,72 | 5,17 | 28,53 |
| Aktsiad | 362,98 mln. | - | E Fund | 0,20 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,57 | 0 | 0 |
| Aktsiad | 357,69 mln. | - | China Southern | 0,65 | Tervishoid | Hang Seng Hong Kong-Listed Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 0,70 | 0 | 0 |
| Aktsiad | 342,192 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index - CNY - Benchmark TR Net | 25.7.2019 | 47,82 | 2,74 | 22,27 |
| Aktsiad | 323,197 mln. | - | Harvest Funds | 0,60 | Tervishoid | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.2.2023 | 0,66 | 0 | 0 |
| Aktsiad | 322,056 mln. | - | Harvest | 0,60 | Tervishoid | SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net | 27.12.2023 | 0,87 | 0 | 0 |
| Aktsiad | 304,872 mln. | - | Invesco | 0,40 | Tervishoid | NASDAQ / Biotechnology | 7.11.2014 | 46,26 | 4,26 | 21,14 |
| Aktsiad | 272,792 mln. | 8061 | Invesco | 0,56 | Tervishoid | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 85,64 | 2,79 | 23,01 |
| Aktsiad | 268,466 mln. | - | iShares | 0,25 | Tervishoid | Dow Jones U.S. Select Medical Equipment Capped 35/20 Index | 3.8.2020 | 6,52 | 4,68 | 38,63 |
| Aktsiad | 261,162 mln. | - | CI | 0,56 | Tervishoid | Solactive Developed Markets Healthcare 150 CAD Index - CAD - Benchmark TR Net | 17.8.2021 | 22,78 | 0 | 0 |
| Aktsiad | 256,195 mln. | - | Harvest | 0,60 | Tervishoid | CSI Medicine and Health 100 Strategy Index - CNY - Benchmark TR Gross | 24.4.2020 | 0,76 | 0 | 0 |
| Aktsiad | 255,604 mln. | - | Amundi | 0,18 | Tervishoid | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 11,59 | 4,71 | 26,95 |
| Aktsiad | 253,134 mln. | 6681,355 | Invesco | 0,58 | Tervishoid | Dynamic Biotech & Genome Intellidex Index (AMEX) | 23.6.2005 | 68,51 | 4,73 | 32,23 |
| Aktsiad | 252,712 mln. | - | BMO | 0,39 | Tervishoid | Solactive Equal Weight U.S. Health Care Hedged to Canada Index - CAD | 19.5.2010 | 68,59 | 3,90 | 25,57 |
| Aktsiad | 247,293 mln. | - | Guotai | 0,60 | Tervishoid | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,53 | 0 | 0 |
| Aktsiad | 236,149 mln. | - | China Southern | 0,20 | Tervishoid | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,58 | 0 | 0 |
| Aktsiad | 231,678 mln. | - | Bosera | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 22.7.2021 | 0,57 | 0 | 0 |
| Aktsiad | 229,188 mln. | - | Xtrackers | 0,20 | Tervishoid | MSCI Europe Health Care ESG Screened 20-35 Index - EUR | 26.6.2007 | 221,09 | 4,93 | 21,92 |
| Aktsiad | 222,336 mln. | - | Ping An | 0,60 | Tervishoid | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | 16.12.2021 | 0,59 | 0 | 0 |
| Aktsiad | 215,462 mln. | 9829,066 | SPDR | 0,35 | Tervishoid | S&P Healthcare Equipment Select Industry | 26.1.2011 | 90,88 | 2,97 | 31,59 |
| Aktsiad | 210,467 mln. | - | Evolve | 0,74 | Tervishoid | Solactive Global Healthcare 20 CAD Hedged Index - CAD | 25.10.2017 | 20,21 | 5,04 | 28,63 |
| Aktsiad | 197,471 mln. | - | Harvest | 0,60 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 7.5.2024 | 1,00 | 0 | 0 |
| Aktsiad | 186,286 mln. | 9842,8 | Invesco | 0,29 | Tervishoid | S&P SmallCap 600 Capped Health Care Index - Benchmark TR Gross | 7.4.2010 | 45,99 | 3,18 | 24,57 |
| Aktsiad | 182,496 mln. | - | BetaShares | 0,57 | Tervishoid | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | 4.8.2016 | 8,17 | 4,95 | 27,37 |
| Aktsiad | 163,523 mln. | - | ICBC | 0,52 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 9.2.2021 | 0,51 | 0 | 0 |
| Aktsiad | 163,055 mln. | 131 294,6 | Simplify | 0,50 | Tervishoid | | 7.10.2021 | 30,89 | 4,75 | 27,56 |
| Aktsiad | 161,719 mln. | 31 454,33 | SPDR | 0,35 | Tervishoid | S&P Pharmaceuticals Select Industry | 19.6.2006 | 46,29 | 2,90 | 18,71 |
| Aktsiad | 160,911 mln. | 25 909,27 | Direxion | 0,96 | Tervishoid | Health Care Select Sector | 15.6.2011 | 106,35 | 5,16 | 28,51 |